Spotting Red Flags: Understanding how Biotech Top Line Press Releases Can "Trick" Investors.Ticker(s): IBX
A clinical trial design expert with experience over decades reviewing raw trial data and planning new trials.
This conversation will pull real life examples of press releases and delays to illustrate issues.
196Days Left to Join Project
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.